We're here to help

Have a question for Merck Animal Health? We're always here to help.

To report an adverse reaction, product-related problem, or human exposure, please call Merck Animal Health Technical Services:


1-800-224-5318

8:30 am - 5:00 pm ET


For after-hours emergencies, please call the number shown above. A recorded message will provide the telephone numbers for emergency support services if immediate assistance is needed.

SAVE MORE WITH BRAVECTO

A single Bravecto treatment lasts for 12 weeks* compared to other products which must be given every month. That makes Bravecto a cost-effective option for keeping your pet protected. But now, you can save even more.

SEE OFFER

Try Bravecto and experience the difference it makes in the lives of you and your pet. Bravecto provides 12 weeks* of protection against fleas and ticks with a single treatment.1,2 That's easy and convenient treating, fewer chances to forget and a better experience for you and your pet, all taken care of with just one dose.

FIND A VET NEAR YOU

Bravecto is only available through your veterinarian. Find a veterinarian near you today to protect your pet with Bravecto.

For technical assistance or to report a suspected adverse drug reaction, contact Merck Animal Health at 1-800-224-5318.

Bravecto kills fleas and prevents flea infestations for 12 weeks. Bravecto Chew kills ticks (black-legged tick, American dog tick, and brown dog tick) for 12 weeks and also kills lone star ticks for 8 weeks. Bravecto Topical Solution for Cats kills ticks (black-legged tick) for 12 weeks and American dog ticks for 8 weeks.

IMPORTANT SAFETY INFORMATION:
Bravecto has not been shown to be effective for 12-weeks’ duration in puppies or kittens less than 6 months of age. Bravecto Chew: The most common adverse reactions recorded in clinical trials were vomiting, decreased appetite, diarrhea, lethargy, polydipsia, and flatulence. Bravecto is not effective against lone star ticks beyond 8 weeks of dosing. Bravecto Topical Solution for Cats: The most common adverse reactions recorded in clinical trials were vomiting, itching, diarrhea, hair loss, decreased appetite, lethargy, and scabs/ulcerated lesions. Bravecto is not effective against American dog ticks beyond 8 weeks of dosing. For topical use only. Avoid oral ingestion. The safety of Bravecto has not been established in breeding, pregnant and lactating cats. Use with caution in cats with a history of neurologic abnormalities. Neurologic abnormalities have been reported in cats receiving Bravecto, even in cats without a history of neurologic abnormalities.

References: 1. Bravecto Chews for Dogs [prescribing information]. Madison, NJ: Merck Animal Health; 2014. 2. Bravecto Topical Solution for Cats [prescribing information]. Madison, NJ: Merck Animal Health; 2016.

Buy Bravecto